Exposing Clinical Labs Budget Blind Spots When it comes to clinical laboratories, professionals should be aware of more than just performing tests. Being knowledgeable of budgets and finances plays a significant role in whether a clinical lab is seen as a profit center, rather than a cost center. Learn More
How Labs in the U.S. Are Responding to COVID-19 With testing in the global spotlight, two laboratorians share their stories of bringing up testing as regulatory hurdles, shortages of test components, and a rapidly expanding pandemic stressed laboratories unlike anything before. Learn More
Next-Generation Sequencing Bioinformatics Pipelines With the advancement of next-generation sequencing based tests, clinical labs turn to bioinformatics pipelines to analyze and process data. When implementing bioinformatics pipelines, lab professionals must consider a variety of resources to ensure consistent efficiency. Learn More
Parkinson’s Disease Playbook Even as the cause of Parkinson’s disease remains elusive, the search is on for biomarkers that would enable earlier diagnosis of this debilitating movement disorder, track its progression, and support effective targeted therapies. Learn More
Genetic Testing for Primary Immunodeficiency Disorders Thanks to recent technological advances, genetic testing has become a prominent method for diagnosis of primary immunodeficiency disorders and is enabling healthcare professionals to better personalize treatment for patients. Learn More
A Lean Approach to Shortening Turnaround Time for Assessing Whole Blood Tacrolimus Levels Lab professionals at UCLA Health System implemented Lean techniques in analyzing blood tacrolimus. With a goal of reducing waiting time for patients, the laboratorians recommended labs begin implementing the same approaches to increase patient satisfaction and laboratory productivity. Learn More
Lab Act Passes, But Cuts Can Continue After a 1-year delay, Congress officially passed the Laboratory Access for Beneficiaries Act to improve the process of data collection for the Protecting Access to Medicare Act, which benefits senior patients. Learn More
Veracyte Expands Reach with NanoString Deal Through a $50 million deal Veracyte acquires access to the NanoString Technology nCounter Analysis System to expand its diagnostics platform globally. The agreement allows Veracyte to use technology to advance genomic testing in hospitals and laboratories worldwide. Learn More
FDA Authorizes Roche’s Novel Diagnostic Test for Detecting MRSA Bacteria FDA has newly authorized Roche’s cobas vivoDX MRSA diagnostic test, which detects MRSA bacteria and determines the best treatment method for patients in as little as 5 hours. The test has shown greater than 90% accuracy in identifying MRSA. Learn More
Sepsis Accounts for 20% of Deaths Globally Double Prior Estimates New research shows the total percentage of deaths due to sepsis is double than original estimates. The findings reveal who and where sepsis is mostly likely to affect, and the vital need for prevention and treatment. Learn More